Search

everythinglearnresearchcommunity

for

Search:↓

Hyaluronic acid microneedles help deliver minoxidil derivatives effectively for hair regrowth.

The new hydrogel helps heal diabetic wounds by reducing inflammation and improving tissue repair.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Acne not improved by usual treatments may indicate a genetic disorder.

Lychnophora salicifolia extract in liposomes may protect skin from UV damage and inflammation.

New compounds were made that are promising for prostate cancer therapy.

Valproic acid treatment increases a specific acid in urine by blocking an enzyme, possibly causing skin rash and hair loss.

JAK inhibitors are effective treatments for alopecia areata.

Enzyme replacement therapy may help alleviate symptoms in complex cases like this.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Spironolactone can reduce hair growth in women with hirsutism.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Spironolactone effectively treats hormonal acne, hair loss, and excess hair growth in women.

Idiopathic hirsutism may be linked to increased skin enzyme activity, and new treatments like laser and eflornithine cream show promise.

Transglutaminase does not modify human hair.

The hydrogel improves hair growth treatment by enhancing drug delivery and promoting follicle repair.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

The treatment with Shunyou and prednisone is effective and safe for lupus nephritis.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

Certain enzymes react strongly with some hormones in rat skin during hair growth, mainly in sebaceous glands and hair sheaths.

The inhibitor DPP can promote hair growth.

Elagolix did not effectively treat polycystic ovary syndrome.

Targeting ornithine decarboxylase can help prevent skin cancer.

The first Japanese case of a genetic hair disorder caused by specific mutations in the LIPH gene was identified.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.